A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
Clinical trial NCT06508307 · RECRUITING
Trial details
- NCT number
- NCT06508307
- Sponsor
- GONGCHU Biotechnology Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-26
- Primary completion
- 2026-01-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.